Genetic Testing for Children with Familial Hypercholesterolemia

Area of Science:

• Genetics
• Pediatrics
• Cardiology

Background:

• Familial hypercholesterolemia (FH) is a common genetic disorder affecting approximately 1 in 300 individuals.
• Cardiovascular disease, the primary complication of FH, often manifests in adulthood for heterozygous cases.
• Early intervention in childhood can prevent the onset of cardiovascular complications.

Purpose of the Study:

• To review the importance and application of genetic testing for diagnosing FH in children.
• To discuss the latest findings on universal screening incorporating genetic testing for pediatric FH.
• To highlight the significance of developing proactive pediatric FH management strategies.

Main Methods:

• Review of existing research on genetic testing for pediatric FH.
• Analysis of the utility of genetic testing in clinical diagnosis.
• Exploration of universal screening approaches for FH in children.

Main Results:

• Clinical diagnosis of FH in children is challenging due to the infrequent manifestation of physical indicators.
• Genetic testing for FH is now covered by national health insurance in Japan since 2022, making it accessible for children.
• The paper synthesizes research on genetic testing's role in early FH detection and management.

Conclusions:

• Genetic testing is vital for the early and accurate diagnosis of FH in children, especially when clinical signs are absent.
• Implementing universal screening with genetic testing can significantly improve pediatric FH management.
• Proactive management of childhood FH is expected to reduce future cardiovascular complications.